Finance

Beta
Lists
Q1 2027 earnings • released • Revenue beat +8.52%
See results
4369:TYO
Tri Chemical Laboratories Inc
Â¥4,050.00
-3.11%
(-130.00) 1D
Jun 2, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4369...
Open
Â¥4,205
High
Â¥4,225
Low
Â¥3,930
Mkt. cap
131.62B
Avg. vol.
764.75K
Volume
1.13M
P/E ratio
21.36
52-wk high
Â¥4,225
52-wk low
Â¥2,455
EPS
Â¥190
Shares outstanding
7.81M
No. of employees
313
Open
Â¥4,205
High
Â¥4,225
Low
Â¥3,930
Mkt. cap
131.62B
Avg. vol.
764.75K
Volume
1.13M
P/E ratio
21.36
52-wk high
Â¥4,225
52-wk low
Â¥2,455
EPS
Â¥190
Shares outstanding
7.81M
No. of employees
313
News stories
From sources across the web
About Tri Chemical Laboratories Inc
CEO-
Employees313
FoundedDec 6, 1978
Headquarters-
SectorSemiconductor
Last report
May 29, 2026
Fiscal period
Q1 2027
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
7.49B / 6.90B
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
5.81B
5.64B
5.87B
7.49B
Cost of goods sold
3.57B
3.49B
3.71B
4.69B
Cost of revenue
3.57B
3.49B
3.71B
4.69B
Research and development expenses
-
-
606.00M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
766.05M
758.51M
131.52M
730.00M
Operating expense
766.05M
758.51M
817.52M
730.00M
Total operating expenses
4.34B
4.25B
4.53B
5.42B
Operating income
1.47B
1.38B
1.34B
2.07B
Other non operating income
7.49M
-36.17M
-43.75M
-
EBT including unusual items
2.16B
1.66B
1.63B
2.48B
EBT excluding unusual items
2.16B
1.66B
1.63B
2.48B
Income tax expense
590.53M
413.68M
137.00M
630.00M
Effective tax rate
27.35%
24.94%
8.40%
25.35%
Other operating expenses
-
-
-
-
Net income
1.57B
1.24B
1.49B
1.86B
Net profit margin
27.02%
22.09%
25.43%
24.77%
Earnings per share
-
-
-
-
Interest and investment income
665.00K
6.48M
426.00K
3.00M
Interest expense
-5.79M
-6.82M
-14.56M
-22.00M
Net interest expenses
-5.12M
-340.00K
-14.13M
-19.00M
Depreciation and amortization charges
-
-
80.00M
-
EBITDA
1.91B
1.86B
1.92B
2.55B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more